These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 28445256)
1. Cost-effectiveness analysis of ultrasonography screening for nonalcoholic fatty liver disease in metabolic syndrome patients. Phisalprapa P; Supakankunti S; Charatcharoenwitthaya P; Apisarnthanarak P; Charoensak A; Washirasaksiri C; Srivanichakorn W; Chaiyakunapruk N Medicine (Baltimore); 2017 Apr; 96(17):e6585. PubMed ID: 28445256 [TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand. Phisalprapa P; Supakankunti S; Chaiyakunapruk N J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247 [No Abstract] [Full Text] [Related]
3. Weight Reduction and Pioglitazone are Cost-Effective for the Treatment of Non-Alcoholic Fatty Liver Disease in Thailand. Chongmelaxme B; Phisalprapa P; Sawangjit R; Dilokthornsakul P; Chaiyakunapruk N Pharmacoeconomics; 2019 Feb; 37(2):267-278. PubMed ID: 30430467 [TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness and budget impact analysis of infliximab and its biosimilar in patients with refractory moderate-to-severe Crohn's disease using real world evidence in Thailand. Phisalprapa P; Kositamongkol C; Limsrivilai J; Aniwan S; Charatcharoenwitthaya P; Pisespongsa P; Kitiyakara T; Treepongkaruna S; Chaiyakunapruk N J Med Econ; 2020 Nov; 23(11):1302-1310. PubMed ID: 32729347 [TBL] [Abstract][Full Text] [Related]
5. Cost-Effectiveness Analysis of Hepatocellular Carcinoma Surveillance in Nonalcoholic Fatty Liver Disease Cirrhosis Using US Visualization Score C-Triggered Abbreviated MRI. Mulgaonkar A; Huang DQ; Siddiqi H; Fowler K; Sirlin CB; Marks R; Loomba R; Konijeti GG Am J Gastroenterol; 2024 Jul; 119(7):1326-1336. PubMed ID: 38146873 [TBL] [Abstract][Full Text] [Related]
6. Economic evaluation and budget impact analysis of the surveillance program for hepatocellular carcinoma in Thai chronic hepatitis B patients. Sangmala P; Chaikledkaew U; Tanwandee T; Pongchareonsuk P Asian Pac J Cancer Prev; 2014; 15(20):8993-9004. PubMed ID: 25374242 [TBL] [Abstract][Full Text] [Related]
12. An economic evaluation of an abdominal aortic aneurysm screening program in Italy. Giardina S; Pane B; Spinella G; Cafueri G; Corbo M; Brasseur P; Orengo G; Palombo D J Vasc Surg; 2011 Oct; 54(4):938-46. PubMed ID: 21820837 [TBL] [Abstract][Full Text] [Related]
13. Screening for Nonalcoholic Steatohepatitis in Individuals with Type 2 Diabetes: A Cost-Effectiveness Analysis. Corey KE; Klebanoff MJ; Tramontano AC; Chung RT; Hur C Dig Dis Sci; 2016 Jul; 61(7):2108-17. PubMed ID: 26825843 [TBL] [Abstract][Full Text] [Related]
14. Cost-Effectiveness Analysis of the Self-Management Program for Thai Patients with Metabolic Syndrome. Sakulsupsiri A; Sakthong P; Winit-Watjana W Value Health Reg Issues; 2016 May; 9():28-35. PubMed ID: 27881256 [TBL] [Abstract][Full Text] [Related]
15. Long-Term Cost-Effectiveness of Insulin Glargine Versus Neutral Protamine Hagedorn Insulin for Type 2 Diabetes in Thailand. Permsuwan U; Chaiyakunapruk N; Dilokthornsakul P; Thavorn K; Saokaew S Appl Health Econ Health Policy; 2016 Jun; 14(3):281-92. PubMed ID: 26961276 [TBL] [Abstract][Full Text] [Related]
16. Economic Evaluation of Intravenous Immunoglobulin plus Corticosteroids for the Treatment of Steroid-Resistant Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Thailand. Bamrungsawad N; Upakdee N; Pratoomsoot C; Sruamsiri R; Dilokthornsakul P; Dechanont S; Wu DB; Dejthevaporn C; Chaiyakunapruk N Clin Drug Investig; 2016 Jul; 36(7):557-66. PubMed ID: 27113227 [TBL] [Abstract][Full Text] [Related]
17. Cost-utility analysis of atezolizumab combined with bevacizumab for unresectable hepatocellular carcinoma in Thailand. Sriphoosanaphan S; Pantumongkol W; Kulpeng W; Charonpongsuntorn C; Tanwandee T; Sukeepaisarnjaroen W; Sobhonslidsuk A; Tangkijvanich P PLoS One; 2024; 19(3):e0300327. PubMed ID: 38512900 [TBL] [Abstract][Full Text] [Related]
18. Cost-utility analysis of an alcohol policy in Thailand: a case study of a random breath testing intervention. Vichitkunakorn P; Khampang R; Leelahavarong P; Nontarak J; Assanangkornchai S BMC Health Serv Res; 2024 Jun; 24(1):739. PubMed ID: 38886718 [TBL] [Abstract][Full Text] [Related]
19. Cost-utility analysis of orthoptic screening in kindergarten: a Markov model based on data from Germany. König HH; Barry JC Pediatrics; 2004 Feb; 113(2):e95-108. PubMed ID: 14754978 [TBL] [Abstract][Full Text] [Related]
20. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation. Shepherd J; Jones J; Takeda A; Davidson P; Price A Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]